Biotechnological applications of an insect-specific alphavirus

Jesse H. Erasmus, Scott Weaver

Research output: Contribution to journalArticle

Abstract

The coupling of viral and arthropod host diversity, with evolving methods of virus discovery, has resulted in the identification and classification of a growing number of novel insect-specific viruses (ISVs) that appear to be evolutionarily related to many human pathogens but have either lost or have yet to gain the ability to replicate in vertebrates. The discovery of ISVs has raised many questions as to the origin and evolution of many human pathogenic viruses and points to the role that arthropods may play in this evolutionary process. Furthermore, the use of ISVs to control the transmission of arthropod-borne viruses has been proposed and demonstrated experimentally. Previously, our laboratory reported on the discovery and characterization of Eilat virus (EILV), an insect-specific alphavirus that phylogenetically groups within the mosquito-borne clade of medically relevant alphaviruses, including eastern equine encephalitis virus (EEEV) and Venezuelan equine encephalitis virus (VEEV), as well as chikungunya virus (CHIKV). Despite its evolutionary relationship to these human pathogens, EILV is unable to replicate in vertebrate cells due to blocks at attachment/entry and RNA replication. We recently demonstrated that, using a chimeric virus approach, EILV could be utilized as a platform for vaccine and diagnostic development, serving as a proof-of-concept for other ISVs. Due to the vast abundance of ISVs, there is an untapped resource for the development of vaccines and diagnostics for a variety of human pathogens and further work in this area is warranted.

Original languageEnglish (US)
Pages (from-to)1045-1049
Number of pages5
JournalDNA and Cell Biology
Volume36
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Insect Viruses
Alphavirus
Insects
Viruses
Arthropods
Vertebrates
Eastern equine encephalitis virus
Vaccines
Venezuelan Equine Encephalitis Viruses
Chikungunya virus
Arboviruses
Culicidae
RNA

Keywords

  • chikungunya
  • diagnostic
  • Eilat virus
  • insect-specific virus
  • vaccine

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Biotechnological applications of an insect-specific alphavirus. / Erasmus, Jesse H.; Weaver, Scott.

In: DNA and Cell Biology, Vol. 36, No. 12, 01.12.2017, p. 1045-1049.

Research output: Contribution to journalArticle

Erasmus, Jesse H. ; Weaver, Scott. / Biotechnological applications of an insect-specific alphavirus. In: DNA and Cell Biology. 2017 ; Vol. 36, No. 12. pp. 1045-1049.
@article{c0cf53e8cebb4d01936ac2062da376b7,
title = "Biotechnological applications of an insect-specific alphavirus",
abstract = "The coupling of viral and arthropod host diversity, with evolving methods of virus discovery, has resulted in the identification and classification of a growing number of novel insect-specific viruses (ISVs) that appear to be evolutionarily related to many human pathogens but have either lost or have yet to gain the ability to replicate in vertebrates. The discovery of ISVs has raised many questions as to the origin and evolution of many human pathogenic viruses and points to the role that arthropods may play in this evolutionary process. Furthermore, the use of ISVs to control the transmission of arthropod-borne viruses has been proposed and demonstrated experimentally. Previously, our laboratory reported on the discovery and characterization of Eilat virus (EILV), an insect-specific alphavirus that phylogenetically groups within the mosquito-borne clade of medically relevant alphaviruses, including eastern equine encephalitis virus (EEEV) and Venezuelan equine encephalitis virus (VEEV), as well as chikungunya virus (CHIKV). Despite its evolutionary relationship to these human pathogens, EILV is unable to replicate in vertebrate cells due to blocks at attachment/entry and RNA replication. We recently demonstrated that, using a chimeric virus approach, EILV could be utilized as a platform for vaccine and diagnostic development, serving as a proof-of-concept for other ISVs. Due to the vast abundance of ISVs, there is an untapped resource for the development of vaccines and diagnostics for a variety of human pathogens and further work in this area is warranted.",
keywords = "chikungunya, diagnostic, Eilat virus, insect-specific virus, vaccine",
author = "Erasmus, {Jesse H.} and Scott Weaver",
year = "2017",
month = "12",
day = "1",
doi = "10.1089/dna.2017.4019",
language = "English (US)",
volume = "36",
pages = "1045--1049",
journal = "DNA and Cell Biology",
issn = "1044-5498",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Biotechnological applications of an insect-specific alphavirus

AU - Erasmus, Jesse H.

AU - Weaver, Scott

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The coupling of viral and arthropod host diversity, with evolving methods of virus discovery, has resulted in the identification and classification of a growing number of novel insect-specific viruses (ISVs) that appear to be evolutionarily related to many human pathogens but have either lost or have yet to gain the ability to replicate in vertebrates. The discovery of ISVs has raised many questions as to the origin and evolution of many human pathogenic viruses and points to the role that arthropods may play in this evolutionary process. Furthermore, the use of ISVs to control the transmission of arthropod-borne viruses has been proposed and demonstrated experimentally. Previously, our laboratory reported on the discovery and characterization of Eilat virus (EILV), an insect-specific alphavirus that phylogenetically groups within the mosquito-borne clade of medically relevant alphaviruses, including eastern equine encephalitis virus (EEEV) and Venezuelan equine encephalitis virus (VEEV), as well as chikungunya virus (CHIKV). Despite its evolutionary relationship to these human pathogens, EILV is unable to replicate in vertebrate cells due to blocks at attachment/entry and RNA replication. We recently demonstrated that, using a chimeric virus approach, EILV could be utilized as a platform for vaccine and diagnostic development, serving as a proof-of-concept for other ISVs. Due to the vast abundance of ISVs, there is an untapped resource for the development of vaccines and diagnostics for a variety of human pathogens and further work in this area is warranted.

AB - The coupling of viral and arthropod host diversity, with evolving methods of virus discovery, has resulted in the identification and classification of a growing number of novel insect-specific viruses (ISVs) that appear to be evolutionarily related to many human pathogens but have either lost or have yet to gain the ability to replicate in vertebrates. The discovery of ISVs has raised many questions as to the origin and evolution of many human pathogenic viruses and points to the role that arthropods may play in this evolutionary process. Furthermore, the use of ISVs to control the transmission of arthropod-borne viruses has been proposed and demonstrated experimentally. Previously, our laboratory reported on the discovery and characterization of Eilat virus (EILV), an insect-specific alphavirus that phylogenetically groups within the mosquito-borne clade of medically relevant alphaviruses, including eastern equine encephalitis virus (EEEV) and Venezuelan equine encephalitis virus (VEEV), as well as chikungunya virus (CHIKV). Despite its evolutionary relationship to these human pathogens, EILV is unable to replicate in vertebrate cells due to blocks at attachment/entry and RNA replication. We recently demonstrated that, using a chimeric virus approach, EILV could be utilized as a platform for vaccine and diagnostic development, serving as a proof-of-concept for other ISVs. Due to the vast abundance of ISVs, there is an untapped resource for the development of vaccines and diagnostics for a variety of human pathogens and further work in this area is warranted.

KW - chikungunya

KW - diagnostic

KW - Eilat virus

KW - insect-specific virus

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85039845585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039845585&partnerID=8YFLogxK

U2 - 10.1089/dna.2017.4019

DO - 10.1089/dna.2017.4019

M3 - Article

C2 - 29161110

AN - SCOPUS:85039845585

VL - 36

SP - 1045

EP - 1049

JO - DNA and Cell Biology

JF - DNA and Cell Biology

SN - 1044-5498

IS - 12

ER -